Description
Recombinant monoclonal antibody to CD80. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma B7-24.
Target
CD80
Target Alias Names
BB1, B7, B7-1, B7.1, CD28LG, CD28LG1, LAB7, Activation B7-1 antigen, T-lymphocyte activation antigen CD80, CTLA-4 counter-receptor B7.1, B-lymphocyte activation antigen B7, CD80 antigen (CD28 antigen ligand 1, B7-1 antigen), costimulatory factor CD80, costimulatory molecule variant IgV-CD80, CTLA4L, CTLA-4L
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression